Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124035425 | 12403542 | 5 | F | 20160517 | 20160705 | 20160525 | 20160712 | EXP | PHHY2016ZA069855 | NOVARTIS | 42.45 | YR | F | Y | 0.00000 | 20160712 | CN | ZA | ZA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124035425 | 12403542 | 1 | PS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | 0.5 MG, UNK | S0124 | 22527 | .5 | MG | CAPSULE | ||||||
| 124035425 | 12403542 | 2 | SS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | 0.5 MG, UNK | S0147 | 22527 | .5 | MG | CAPSULE | ||||||
| 124035425 | 12403542 | 3 | C | VENLOR | VENLAFAXINE HYDROCHLORIDE | 1 | Unknown | 75 MG, QD | U | 0 | 75 | MG | QD | ||||||
| 124035425 | 12403542 | 4 | C | VENLOR | VENLAFAXINE HYDROCHLORIDE | 1 | Unknown | 150 MG, QD | U | 0 | 150 | MG | QD | ||||||
| 124035425 | 12403542 | 5 | C | LYRICA | PREGABALIN | 1 | Unknown | UNK, BID | U | 0 | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124035425 | 12403542 | 1 | Multiple sclerosis |
| 124035425 | 12403542 | 3 | Product used for unknown indication |
| 124035425 | 12403542 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124035425 | 12403542 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124035425 | 12403542 | Asthenia | |
| 124035425 | 12403542 | Blood pressure fluctuation | |
| 124035425 | 12403542 | Dry mouth | |
| 124035425 | 12403542 | Dysgeusia | |
| 124035425 | 12403542 | Dyspnoea | |
| 124035425 | 12403542 | Eye pain | |
| 124035425 | 12403542 | Fall | |
| 124035425 | 12403542 | Fatigue | |
| 124035425 | 12403542 | Feeling abnormal | |
| 124035425 | 12403542 | Gait disturbance | |
| 124035425 | 12403542 | Headache | |
| 124035425 | 12403542 | Heart rate decreased | |
| 124035425 | 12403542 | Hyperaesthesia | |
| 124035425 | 12403542 | Lethargy | |
| 124035425 | 12403542 | Malaise | |
| 124035425 | 12403542 | Muscular weakness | |
| 124035425 | 12403542 | Nasopharyngitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124035425 | 12403542 | 1 | 20160517 | 0 |